Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis

Abstract

Lack of benefit from fluticasone propionate was most likely due to failure of the drug to penetrate the viscid mucus lining the airways. It is suggested a large multicentre trial with higher doses given for a longer time by a different delivery system is required to assess efficacy.